MEI Pharma Inc. (NASDAQ:MEIP) announced the signing of agreements to purchase securities in a private investment in a public company valued at approximately $100 million. The pharmaceutical company plans to use the full net proceeds to acquire Litecoin as a primary reserve asset for its treasury.
GSR will act as the company's advisor in managing digital assets and treasury. Among other participants in the investment are the Litecoin Foundation and venture capital firms MOZAYYX, ParaFi, Hivemind, Primitive, RLH Capital, Delta Blockchain, and CoinFund
